High-Performance Separation-Electrospray Ionization System
High-Performance Separation-Electrospray Ionization System
AB Sciex introduces the CESI 8000 System for Biologics Characterization, a high-performance separation-electrospray ionization system for mass spectrometry. CESI combines capillary electrophoresis (CE) and electrospray ionization (CESI). This new front-end CESI technology from the company’s SCIEX Separations business can be integrated with the AB Sciex TripleTOF 5600+ MS system.
The CESI 8000 provides improved results compared to dual-method liquid chromatography/mass spectrometry-based approaches. From a single digest and run, users of CESI-MS gain identity and purity information with 100% coverage in a peptide map, heterogeneity information with ultrasensitive glycopeptide quantitation, and stability information identifying, deamidation, cyclization, and oxidation.
According to the company, CESI technology is designed to improve biophysicochemical characterization and guide the development of biologics-based therapeutics. Specifically, CESI-MS serves to improve ionization efficiency and reduce ion suppression.
AB Sciexa
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
July 16th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.
